Chronic Iron Overload Due to Transfusion-dependant Anemias
1 clinical trials · Condition
◉ Watch Chronic Iron Overload Due to Transfusion-dependant Anemias
| Record | Firm | Date |
|---|---|---|
| Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet) (NCT02125877) | Novartis Pharmaceuticals | 2014-07-08 |
Track Chronic Iron Overload Due to Transfusion-dependant Anemias automatically
Every clearance here is in the API, with alerts when new ones post.